Browse
You are looking at 11 - 20 of 22 items for :
- Kidney Week x
- Refine by Content Type: All x
WASHINGTON, DC – The effects of plant-based diets and phosphorous restriction on kidney disease were the subject of two talks presented at Kidney Week 2019.
Plant-based diets may be good for people with kidney disease, said Juan Jesus Carrero, MD, PharmD, PhD, a professor of epidemiology with the Karolinska Institute in Sweden. Plant proteins had been viewed as having low biological value, he said, because when dietary guidelines were issued, it was believed impossible to acquire complete essential amino acids from plant foods. However, numerous trials and meta analyses conducted over the past 20 years have proved that theory wrong. Fruit and vegetable intake has been shown to offer numerous health benefits such as lowering the risk of chronic kidney disease (CKD), end-stage renal disease (ESRD) and death, and delaying the progression of kidney disease.
WASHINGTON – Caloric restriction, whether through diet, bariatric surgery, or new sodium-glucose cotransporter-2 inhibitor (SGLT2) medications, could help improve measures of kidney disease in obese patients, according to a Kidney Week 2019 presentation.
As people gain weight, their metabolic rate increases, said Holly J. Kramer, MD, MPH, a professor of public health sciences and medicine in the Division of Nephrology and Hypertension at Loyola University in Chicago, during a talk on the direct and indirect effects of adiposity on the kidney. The kidneys then have to do more, and meet the increased demands by increasing the glomerular diameter so it hypertrophies, yielding an increase in glomerular filtration rate and an increase in renal plasma flow.
WASHINGTON, DC – Children with chronic kidney disease (CKD) have structural changes in the brain associated with poorer intelligence, executive function and academic achievement, compared to healthy children without the disease, according to new research from the University of Iowa presented at Kidney Week 2019 in a session entitled, “Pediatric CKD Is Associated with Abnormal White Matter Integrity” .
An exciting, and sometimes heated, panel and audience discussion occurred today at Kidney Week 2019 on the subject of disruptors in the nephrology market. Major new healthcare players are entering kidney care, bringing perspectives and expertise on technology, big data, and artificial intelligence and integrated payer-provider platforms. These innovators are working to transform the landscape in kidney care. The audience was standing room only and the hour-long question period had a line the entire time.
WASHINGTON, DC -- Biopsies remain the gold standard for diagnosing post-transplant kidney disease but they are imperfect, a speaker said here during Kidney Week 2019. Emerging biomarkers may provide a complement to helping nephrologists diagnose and manage disease. The session entitled, "Needle Phobia: Kidney Transplant Biopsy Alternatives" , included four speakers on the topic.
During Kidney Week 2018, the American Society of Nephrology (ASN) is releasing daily podcasts covering the interesting topics of each day in San Diego.
Featured are talks lead by ASN President Mark D. Okusa, MD, FASN and ASN Program Committee Chair Benjamin D. Humphreys, MD, PhD, FASN.
The first daily Kidney Week 2018 podcast features ASN President, Mark D. Okusa MD, FASN, who speaks with Catherine Godson, PhD; John K. Roberts, MD, MS; and Dinushika Mohottige, MD, MPH about the first day of the annual meeting.
2018 ASN Kidney Week officially kicked off on October 25 with a Plenary Session focused on the changing dynamics in nephrology and the influence of policy and advocacy in achieving innovations in care. ASN President, Dr. Mark Okusa, MD, FASN, delivered his opening remarks with not just aspirational goals for the direction of nephrology, but also outlining the stark realities confronting nephrology.
ASN Kidney Week begins October 25 in San Diego, California. As the largest nephrology meeting in the world, ASN Kidney Week offers an overwhelming amount of content on a wide variety of subjects. For attendees interested in innovations in clinical trials and developing new therapies for people living with kidney diseases, there are a few must see sessions whose speakers are members of the Kidney Health Initiative (KHI) .
Announced this year, there will be a brand-new session occurring at Kidney Week 2018 in San Diego on October 25. The session focuses on significant publications in the Journal of the American Society of Nephrology (JASN) and the Clinical Journal of the American Society of Nephrology (CJASN) from this past year.
Editor-in-Chief of JASN, Josephine P. Briggs, MD, and Editor-in-Chief of CJASN, Rajnish Mehrotra, MD, MBBS, FASN, will moderate the session, highlighting innovative clinical, translational, and basic research in nephrology. Topics will also cover diverse, novel, and clinically applicable science across a variety of nephrology disciplines.
